Beurer GL44 lean
37
tested with the Beurer GL44 lean blood glucose monitoring system; therefore, using the device
with these samples is not recommended.
3. In the case of severely ill patients, blood glucose monitors for home use should not be used.
4. The e
ff
ect of interfering substances on the measurements depends on the concentration in the
blood. The maximum concentrations of certain substances listed below do not significantly influ-
ence the measurements.
Concentration of
tested substances
50-100
mg/dL
(2.8-5.6
mmol/L)
250-350
mg/dL
(13.9-19.4
mmol/L)
Acetaminophen
7
mg/dL
(0.46
mmol/L)
6.6
mg/dL
(0.37
mmol/L)
4.5%
Ascorbic acid
4
mg/dL
(0.23
mmol/L)
3.3
mg/dL
(0.18
mmol/L)
5.1%
Bilirubin
3.3
mg/dL
(0.06
mmol/L)
0.1
mg/dL
(0.01
mmol/L)
-1.4%
Cholesterol
400
mg/dL
(10.34
mmol/L)
-6.8
mg/dL
(-0.38
mmol/L)
-6.2%
Creatinine
30
mg/dL
(2.65
mmol/L)
0.0
mg/dL
(0.00
mmol/L)
-0.1%
Dopamine
2.2
mg/dL
(0.14
mmol/L)
5.0
mg/dL
(0.28
mmol/L)
1.0%
EDTA
5.0
mg/dL
(0.17
mmol/L)
-2.0
mg/dL
(-0.11
mmol/L)
-2.4%
Ephedrine
40
mg/dL
(2.42
mmol/L)
-3.9
mg/dL
(-0.22
mmol/L)
2.4%
Galactose
20
mg/dL
(1.11
mmol/L)
-3.1
mg/dL
(-0.17
mmol/L)
0.5%
Gentisic acid
7
mg/dL
(0.45
mmol/L)
7.2
mg/dL
(0.40
mmol/L)
2.9%
Glutathione
1
mg/dL
(0.03
mmol/L)
-2.6
mg/dL
(-0.14
mmol/L)
-3.7%
Haemoglobin
300
mg/dL
(0.05
mmol/L)
-3.1
mg/dL
(-0.17
mmol/L)
-2.6%
Heparin
2.1
mg/dL
(0.0018
mmol/L)
-3.0mg/dL
(-0.17
mmol/L)
-1.3%
Blood glucose
value
Influence
